The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Influenza Treatment Global Market Report 2024, the influenza treatment market is expected to show promising growth in the forecast period.

The influenza treatment market has experienced steady growth in recent years, with significant expansion expected in the coming years. Here’s a look at the key factors driving this growth and the major trends shaping the market.

Current Market Size and Growth

• 2023 Market Size: The influenza treatment market was valued at $6.34 billion in 2023.
• 2024 Projection: It is projected to grow to $6.60 billion in 2024, reflecting a compound annual growth rate (CAGR) of 4.2%.
• Growth Drivers: The market’s expansion is fueled by a rise in influenza cases, increased government funding for research, public awareness campaigns promoting vaccination, global influenza surveillance systems, and improved healthcare facilities.

Future Market Outlook

• 2028 Projection: The market is expected to grow to $7.83 billion by 2028, with a CAGR of 4.4%.
• Contributing Factors: This growth is anticipated due to the introduction of new antiviral drugs, expanded vaccination programs, an increasing elderly population, and advancements in healthcare infrastructure and treatment options.

View More On The Influenza Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Rising Prevalence of Contagious Respirato
ry Illnesses

• Influenza and Other Illnesses: Contagious respiratory illnesses like influenza, RSV, and measles are on the rise, driving demand for treatments.
• Market Impact: The increase in these illnesses, due to factors like higher population densities, inadequate healthcare infrastructure, and international travel, is boosting the influenza treatment market.
• CDC Data: For example, in September 2023, the Centers for Disease Control and Prevention (CDC) reported a significant rise in RSV hospitalizations, highlighting the need for effective influenza and respiratory illness treatments.

Major Companies and Innovations

• Leading Companies: Some key players in the influenza treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, and GlaxoSmithKline Plc.
• Single-Dose Oral Medicines: Companies are focusing on expanding their product offerings with innovative treatments like single-dose oral medicines, which enhance patient compliance and improve treatment outcomes.
  • Genentech’s Xofluza: In August 2022, Genentech Inc. received FDA approval for Xofluza, the first single-dose oral medicine for treating uncomplicated influenza in children.

Strategic Acquisitions and Market Expansion

• Pfizer and ReViral: In June 2022, Pfizer Inc. acquired ReViral, a UK-based biotechnology company specializing in therapies for viral diseases. This acquisition aims to expand Pfizer’s RSV treatment portfolio with innovative therapies like Sisunatovir, an orally administered RSV inhibitor.

Market Segmentation and Regional Insights

• Product Type: The market includes products like Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, and other treatments.
• Route of Administration: Treatments are administered orally or through other routes, depending on the product.
• Distribution Channels: These include retail pharmacies, hospital pharmacies, and other distribution channels.
• Regional Performance: North America was the largest region in the influenza treatment market in 2023. The Asia-Pacific region is expected to be the fastest-growing market in the forecast period, driven by improvements in healthcare infrastructure and increased awareness of influenza treatments.

Conclusion
The influenza treatment market is poised for significant growth in the coming years, driven by rising rates of respiratory illnesses, innovations in treatment options, and strategic acquisitions by major pharmaceutical companies. With continued advancements in healthcare and increasing awareness of the importance of influenza prevention and treatment, the market is set to expand steadily, offering new opportunities for stakeholders across the globe.

Request A Sample Of The Global Influenza Treatment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15832&type=smp